openPR Logo
Press release

IDEX Health & Science Launches Advanced Optofluidic Portfolio at Analytica 2016

05-11-2016 06:32 PM CET | Health & Medicine

Press release from: Idex H&S

Hall A2 - Booth #109, Analytica, May 10-13, 2016, Munich, Germany

Rohnert Park, CA May 11, 2016 - IDEX Health & Science, LCC, the global authority in fluidics and optics for the life sciences market, showcases its newly expanded fluidic and optical components and support at Analytica 2016. This unique combination of fluidic and optical capabilities assists customers in speeding up their time to market and supports the company’s strategic vision to enhance the complete development path with intelligent solutions for life.

Visitors to Analytica will be introduced to IDEX Health & Science’s newly expanded portfolio of fluidic and optical technologies; driven by its recent integration of Semrock and Melles Griot, and the acquisition of CIDRA® Precision Services, announced last July. The fusion between fluidics and optics is further enhanced through the support of IDEX Health & Science’s engineering experts, who share their wealth of engineering expertise, and decades of industry knowledge.

The combination of fluidics and optics allows IDEX Health & Science to deliver a complete spectrum of highly engineered solutions, including rapid prototyping tools that bring together fluidics and optics to support the complete development path for life science instrumentation. This unique blend of programs makes innovation easier and faster than ever. The range and support on offer includes:

Fluidic components and integrated assemblies, including: Fluidic Connections, Valves, Pumps, Degassers, Column Hardware, Manifolds, Flow Cells, Microfluidic Consumables, Sensors, and Integrated Fluidic Systems

Optic components and assemblies, including: Optical Filters, Lenses, Shutters, Lasers & Light Engines, and Integrated Optical Systems

Rapid response programs for reduced development time

Custom module development

Design for manufacturing integration

“The realm of life sciences changes at a rapid pace and our aim is to provide continued support to our customers, to meet their most demanding challenges, and accelerate their time-to-market through a better alignment of people, products, and engineering resources. The fusion of optics and fluidics will enable IDEX Health & Science to continue to exceed customer needs and ensure success,” said Gus Salem, Group President of IDEX Health & Science.

“With the launch of our new optofluidic portfolio, we are excited to be able to add significant value to our customers’ development processes, such as dramatically reducing their production and after-market costs,” Salem continued. “Analytica is the leading fair for state-of-the-art laboratory technology, and we look forward to meeting with customers, partners and key thought leaders to share our new strategic approach and innovative technologies.”

IDEX Health & Science will also be highlighting their MarvelX™ line of next generation connection systems at the show. The MarvelX UHPLC connection system is designed to offer improved routing throughout instrumentation. Innovative features include: biocompatibility, a system requiring no tools or expert equipment to install, tubing that allows flexibility to route throughout an instrument, and connections that are reusable up to 200 times, with an innovative removable nut element for greater flexibility and affordability.

For more information about IDEX Health & Science, please visit booth #109, Hall A2 at Analytica 2016, or visit

The Group President of IDEX Health & Science, Gus Salem, will be leading an Industry News Event at Analytica on Wednesday, May 11th at 15:30 PM (3:30 PM). Salem will share insights on how to leverage intelligent solutions to maximize system performance for early design and rapid innovation. Meet Salem and join the discussion in the Press-Conference-Room at Press-Center West, 2nd Floor.

About IDEX Health & Science LLC

IDEX Health & Science is the global authority in fluidics and optics, bringing life to advanced optofluidic technologies with our products, people and engineering expertise. We are respected worldwide for solving complex problems and delivering complete path innovation for analytical, diagnostic and biotechnology applications for the life sciences market. As a genuine and trustworthy partner, we solve our customers’ most demanding challenges with the industry’s most extensive portfolio of state-of-the-art components and capabilities that are unrivaled in breadth, quality, performance and design. Our vision of the complete path goes far beyond just meeting our customers’ needs — it anticipates them, with intelligent solutions for life.

Product offerings include: connections, valves, pumps, degassers, column hardware, manifolds, flow cells, microfluidic consumables, sensors, integrated fluidic systems, optical filters, lenses, shutters, laser & light engines, and integrated optical systems. For more information, visit:

For further press information please contact: Scott Girling-Heathcote, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA, United Kingdom. Tel +44 1477 539 539 Fax: +44 1477 539 540 Email or Norbert Hax, Tel +49-171-5680856 E-mail:

1 Whiteside
Station Road
Holmes Chapel

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IDEX Health & Science Launches Advanced Optofluidic Portfolio at Analytica 2016 here

News-ID: 340619 • Views:

More Releases from Idex H&S

IDEX Health & Science Announces Acquisition of Finger Lakes Instrumentation
Rohnert Park, CA, July 25, 2018 — IDEX Health & Science, LLC (IH&S) today announced the acquisition of Lima, NY based Finger Lakes Instrumentation, LLC (FLI). Finger Lakes Instrumentation is a technology leader in the design, development and production of low-noise cooled CCD and high-speed, high-sensitivity cooled Scientific CMOS cameras for the astronomy and life science markets. 18 year-old FLI has three facilities located in New York State with 31 employees.
IDEX Health & Science Announces New Optics Center of Excellence in Rochester, NY
PRESS RELEASE FOR IMMEDIATE RELEASE For further information, please contact: Heidi Lechner Tel: +1 707-588-2160 E-mail: IDEX Health & Science Announces New Optics Center of Excellence in Rochester, NY Rohnert Park, CA, August 14, 2017 — IDEX Health & Science, LLC today announced plans to occupy a new, state-of-the-art facility in Rochester, New York that will enable scalable future growth of its optical components, sub-systems, and filters business. In 2014, IDEX Health & Science believed that bringing

More Releases for Health

Digital Therapeutics Market Research 2025 Leading Key Players - Proteus Digital …
An exclusive Digital Therapeutics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Digital Therapeutics Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report
Digital Therapeutics Market Outlook 2025 : Proteus Digital Health, Omada Health, … has announced the addition of the “Global Digital Therapeutics Market Size, Status and Forecast 2025” The report focuses on major leading players with information such as company profiles, product picture and specification. This report studies the global Digital Therapeutics market, analyzes and researches the Digital Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market,
Digital Therapeutics Market Outlook to 2025 - Propeller Health, CANARY HEALTH, N …
The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. The application segment includes, respiratory diseases, central nervous system disease, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented as, B2B and B2C. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and
Digital Therapeutics Market Analysis 2018 | Growth by Top Companies: Proteus Dig …
Global Digital Therapeutics Market to 2025 This report "Digital Therapeutics Market Analysis to 2025" provides an in-depth insight of medical device industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition. The treatment relies on behavioral and
Digital Therapeutics Market 2018 Global Key Player Analysis - Omada Health, Twin …
New Intelligence Report on “Digital Therapeutics Market to 2025” is recently published by The Insight Partners. The report aims to provide leading industry players with information such as company profiles, products and services offered, financial information of last 3 yesars, key development in past five years North America is estimated to contribute to the largest share in the digital therapeutics market in the coming years, owing to factors such as, improved
Digital Therapeutics Market Global Outlook to 2025 - Proteus Digital Health, Wel …
“Digital Therapeutics Market" covers a detailed research on the industry with financial analysis of the major players. The report provides key information and detailed study relating to the industry along with the Economic Impact and Regulatory and Market Support. The report examines the industry synopsis, strategic investments, Industry Surveys, Economic Impact, etc. The market of digital therapeutics market is anticipated to grow with a significant rate in the coming years, owing